SCT 800

Drug Profile

SCT 800

Alternative Names: SCT800

Latest Information Update: 05 Oct 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Sinocelltech
  • Class Blood coagulation factors; Coagulants; Recombinant proteins
  • Mechanism of Action Blood coagulation factor replacements; Factor X stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Haemophilia A

Most Recent Events

  • 29 Sep 2016 Sinocelltech plans a phase III trial for Haemophilia A (In adolescents, In adults, Treatment-experienced) in China (NCT02921945)
  • 20 Sep 2016 Sinocelltech plans a phase I trial for Haemophilia A (In children, In adults, Treatment-experienced) in China (NCT02888223)
  • 25 Jan 2016 Pharmacodynamics data from a preclinical studies in Haemophilia A released by Sinocelltech
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top